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Abstract
Despite the widely held belief of the importance of innovation, the connection between innovation and firm
performance is empirically inconclusive, partially owing to the limitations of existing innovation measures,
which tend to ignore the effectiveness of innovation programs. In this study, we use the winning of innovation
awards as a proxy for the effective execution of innovation. We conducted event-study analyses based on data
from more than 1000 publicly traded firms that won innovation awards between 1998 and 2003. Our statistical
tests provide strong evidence that the performance of award-winning firms is significantly higher as compared
with several sets of control firms. Over an 8-year period, starting from 4 years before to 3 years after the year of
winning the first innovation award, the test sample’s mean (median) change in return on assets is nearly 33%
(24%) higher than that of a control sample. The evidence also suggests that effective innovation programs can
increase firms’ revenue, cost efficiency, and market valuation. Over the period, the control-adjusted mean (median) change in sales, cost per dollar of sales, and Tobin’s Q are 39.28% (20.71%), −5.52% (−3.80%), and 23.70%
(3.16%), respectively. Panel data regression analysis provides additional insights on the performance impact of
effective innovation programs. The results show that award winners are not only financially more successful
but also enjoy an indirect benefit through better R&D execution, which increases firm profitability in both the
short term and long term.
Keywords: innovation awards, effective innovation programs, operational and financial performance, empirical analysis

tiatives across all industries is only about 4.5% (VanGundy 2007). Senior managers are often unsure of the
financial return on R&D spending, or whether they are
satisfied with the efficacy of their innovation programs
as evidenced by the results from the McKinsey and BCG
surveys. Although R&D spending continues to rise in a
large number of companies, its output often falls short
of expectations. As Andrew and Sirkin wrote in their
recent book Payback: Reaping the Rewards of Innovation,
“most attempts at innovation fail to deliver this return—
they do not generate enough payback” (2007, p. 1).
They believe that true innovation is not just about new
ideas, but more importantly, about the capability to convert the ideas into cash or profit. Similarly, O’Brien argues “Being an effective innovator requires more than
just developing new products: it requires getting those
products to market” (2003, p. 420).

1. Introduction
Innovation is widely acknowledged as the key for
achieving and sustaining a firm’s competitive advantage. It is thus not surprising that innovation is often
one of the top priorities for many companies, even during economic downturns (Scheck and Glader 2009). In
recent global surveys conducted by McKinsey (Barsh
et al. 2007) and Boston Consulting Group (Andrew
et al. 2007), the majority of responding business leaders representing almost all industries considered innovation important or even critical to their businesses,
and they planned to increase future spending on such
activities.
Despite the growing importance of innovation to
business success, few companies seem to innovate well.
It was estimated that the success rate of innovation ini1
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The high failure rate of innovation initiatives offers
a possible explanation of the mixed results of prior research on the link between innovation and performance
outcome (Capon et al. 1990, Durand et al. 2008, Li and
Atuahene-Gima 2001). Although useful, existing measures of innovation employed to test this relation often do not adequately capture the notion of innovation effectiveness. For example, input-based measures,
such as R&D expenditures or R&D intensity, only provide information about a firm’s innovative efforts, but
do not reveal whether or not the firm is good at being
innovative. Innovative efforts, however, do not always
translate to improved performance. Terwiesch and Ulrich (2009) showed that there is no clear linkage between R&D spending and firm performance (revenue
growth) in a variety of industries, such as computers,
chemicals, pharmaceuticals, and autos. In their study
of 1000 publicly held companies around the world that
spent the most on research and development, Jaruzelski
et al. (2005) found R&D spending does not affect corporate success in growth, profitability, and shareholder return. Higher R&D expenditures may indicate a higher
level of agency costs (Jensen and Meckling 1976) but not
necessarily better innovation ability (Kochhar and David 1996). Similarly, the connection between outputbased measures, such as patent counts and innovation
effectiveness, is also weak (Griliches 1990). As shown in
previous work (Harhoff et al. 1999), the quality and economic value of patents can vary greatly with some patents being extremely valuable while others being worth
almost nothing. As such, a simple aggregation of patents does not truly reflect their overall utility.
Innovation can be viewed as a two-staged process
(Edwards and Gordon 1984, MacLaurin 1953). The first
is the invention stage where the focus is on basic research (e.g., compound screening for pharmaceutical
companies). However, identifying a new compound
does not necessarily deliver value to consumers. Before the company is able to introduce a successful drug
based on the compound, it has to link the compound’s
use to a specific customer demand, conduct preclinical and clinical trials, and fulfill strict government requirement (cf. Girotra et al. 2007). Our study focuses on
this second stage—commercialization (or development
for commercial use). It is important to note that patent
counts or patent citations reflect the outcome of mainly
the invention part, but indirectly the commercialization
part of the innovation process. While most of the studies in the literature have focused on linking patents or
patent citations to firm performance, our study provides
direct evidence on how innovation through product development and commercialization adds value to firms.
In this study, we seek to justify the returns of an effective innovation program, which we define as an inno-
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vation program that can generate high-impact commercial output and offer substantial value to customers or
the market. This focus is theoretically important because
although there has been a conceptual account of the
general importance of innovation in the field, the empirical evidence remains inconclusive. Furthermore, the
underlying mechanisms and value of innovation have
not yet been fully elucidated. Among issues that have
not been addressed are how innovation matters to firm
operations, what the magnitude of these effects is likely
to be, and whether these effects endure, to mention just
a few. The lack of progress on these fronts is partially
owing to the fact that high-impact innovations are outnumbered by minor, less influential ones. This, when
combined with the limitations of the existing innovation
measures, obscures the effect of innovation on firms.
Our goal of this study is to fill the gap in the literature. We use the winning of innovation awards as a
proxy for the effectiveness of the innovation process.1
Based on a test sample of 1141 publicly traded firms that
won innovation awards during 1998–2003 and their accounting and financial data, we empirically examine the
innovation’s impact on firm performance. Our results
suggest that effective innovation does pay off. As compared with several sets of control firms, the performance
of the award-winning firms examined in this study
shows significant improvement.
There are two major reasons for our choice of award
winning, instead of traditional innovation measures,
such as R&D spending or patent counts, as evidence of
effective innovation programs. First, award providers
commonly use objective and rigorous evaluation criteria
or surveys of consumers in choosing award winners. To
maintain reputation and credibility of their awards, providers are strongly motivated to award only those firms
that are truly innovative (see Hendricks and Singhal
1996, 1997b, and Klassen and McLaughlin 1996 for similar arguments for quality and environmental awards).
For example, the DuPont Award for Innovation in Packaging rewards “innovative products and processes resulting in breakthroughs in sustainable packaging.” The
Nova Award administered by the Construction Innovation Forum is established to “recognize innovations
that have proven to be significant advances that have
had positive, important effects on construction to improve quality and reduce cost.” Computerworld selects
its Innovative Technology Award winners based on a
three-stage process, which starts with an industry-wide
customer nomination, continues on with surveys, and
finalizes with expert evaluation. During the process, all
candidates are fully evaluated based on the innovativeness and originality of their technology, competitive advantage, customer satisfaction, and business impact.
Hence, winning an innovation award provides credible,
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independent external validation about a firm’s innovation commitment and ability.
Second, the measure of innovation awards takes
into consideration some nuanced, but important, differences between innovation and invention, two interrelated, but conceptually distinct constructs. There
is a general consensus among business and economics researchers that an innovation is not merely something new. MacLaurin argued in his early work that
“When an invention is introduced commercially as a
new or improved product or process, it becomes an innovation” (1953, p. 105). Likewise, Edwards and Gordon claimed that innovation is “a process that begins
with an idea, proceeds with the development of an invention, and results in the introduction of a new product, process or service to the marketplace” (1984, p. 1;
see also Danneels 2002, Katila and Shane 2005, Thornhill 2006). Therefore, beyond the newness of the idea,
commercial application is a defining characteristic of
innovation. Award-giving organizations generally incorporate commercial feasibility as a prerequisite for
their award consideration. To illustrate, again we can
use the Innovative Technology Award as an example.
The award provider, Computerworld, highlights in its
evaluation criteria that each qualified candidate should
be able to show some evidence of successful commercial use of its technology.2 Thus, such practice and requirement associated with innovation awards supports
the content validity of the instrument.
By focusing on third-party certified award-winning
innovations, our study provides a benchmark of what
can be expected from an effective innovation program.
It also helps in resolving the controversy about the magnitude of financial returns from innovation. In addition,
by using publically available data on firms’ innovation
effectiveness and their financial performance, we avoid
the potential biases associated with surveying the firms
to obtain their self-reported perceived innovation effectiveness and financial performance.
The next section provides a summary of the relevant
literature on innovation. This is followed by a comparison of major existing innovation measures in Section
3. Section 4 develops the hypotheses. The sample collection and methodology are then detailed in Section 5.
Section 6 discusses the results. The closing section discusses the implications and limitations of the study and
suggests directions for future research.
2. Related Literature
The literature on innovation is vast and growing.
Among this large body of work, a substantial proportion of the research has focused on why firms differ in
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their innovation effort and commitment. O’Brien (2003),
for example, found that financial slack constitutes a vital
complement to the successful execution of innovation
programs. Pennings and Harianto (1992) and Goes and
Park (1997) showed that social capital, through its impact on knowledge access and diffusion in the market,
plays a critical role in a firm’s decision to adopt a new
product or service. Leiponen (2008) echoed the importance of social relations, but from a different perspective. The author detected that the willingness of a company to make investments on innovation is shaped by
its ability to control knowledge output from collaborative relations.
A firm’s propensity to innovate also appears to be
contingent on its own strategic choices and orientation
(Ahuja and Katila 2001, Hitt et al. 1997, Thornhill 2006).
Hitt et al. (1997) argued and found evidence that internationally diversified firms are more inclined to fund research and development because the broadness of their
business scope allows them to take full advantage of
such effort. Ahuja and Katila’s (2001) insightful analysis
showed that technological acquisition can both broaden
firms’ knowledge stock and disrupt their operating routines; thus it can affect innovation outcome in such a
complicated fashion that its ultimate impact is determined by both the absolute and relative size of the acquired knowledge base.
Still, many other factors matter to innovation output.
Among the other factors that have been studied are: executive pay (Balkin et al. 2000), organizational structure (Jansen et al. 2006), manager background (Bantel
and Jackson 1989), internal resource exchange (Tsai and
Ghoshal 1998), institutional investors (Kochhar and David 1996), market competitiveness and size (Katila and
Shane 2005), and industry dynamism (Thornhill 2006).
Given the above findings, firms would naturally differ in their innovation activities. This gives rise to a
question of whether the disparity has a performance implication to firms. Through a comprehensive (but not
necessarily exhaustive) review of the literature, we identified 26 studies (summarized in Table 1)3 that have empirically investigated this question. Together, the evidence generally supports the argument that innovation
is essential to organizational survival and long-term
success. Innovating firms are characterized by higher
stock performance and stronger ability to capture market opportunities (Banbury and Mitchell 1995, Kelm
et al. 1995, Lawless and Anderson 1996, Zhao 2009). For
example, Zhao (2009) found the level and dynamics of
technological innovation is an important predictor of
the future value of a firm’s stock. Kelm et al. (1995) empirically showed that the capital market tends to positively react to firm announcements of R&D projects. On
studying 86 firms in the U.S. implantable cardiac pace-

R&D spending

R&D project
Market value
announcements		

Hull and Rothenberg (2008)

Kelm et al. (1995)

501 R&D project announcements
in 23 industries

69 firms

113 Fortune 500 manufacturers

Sample firms

R&D project announcements increase firm value.

R&D spending improves firm performance.

Firms that invest heavily in R&D have the highest 		
   financial performance.

Key findings/conclusions about the relationship
   between innovation and performance

R&D spending, patents,
    trademarks, and designs

Market value

400 large Austrian firms

R&D activity and patent application can increase
  a firm’s market value.

Patent counts and patent
   citations

New product introduction

New product introduction

New product introduction

New product introduction

New product introduction

Zhao (2009)

Banbury and
   Mitchell (1995)

Chaney et al. (1991)

Freel (2000)

Girotra et al. (2007)

Hendricks and
   Singhal (1997a)

Innovative propensity leads to persistent
   abnormal profit over time.

42 firms in the pharmaceutical
   industry

Return on assets

Roberts (1999)

New product introduction

All firms in the U.S. microNew technology adoption increases a firm’s
computer industry from 1982
performance.
   (86 firms) through 1991 (553 firms)

Delays in product introductions lower
   firm profitability.

There are significant stock market penalties for
   not introducing new products on time.

Lawless and
New product introduction
Market share
Anderson (1996)			

Return on assets,
Nearly 450 publicly traded firms
return on sales, and
  in various industries
sales over assets		

101 firms that announced new
   product delay news

A late-stage failure of a drug development
   project contributes to a significant decline
   in firm value.

and

Market value

132 phase III drug failures in
   the U.S. publicly traded
   pharmaceutical firms

Innovators tend to enjoy high employment growth
   and productivity. They, however, do not
   necessarily have higher sale growth,
   profitability, or export performance than less
   innovative firms.

The announcement of a new product introduction
   increases a firm’s market value.

Both the frequency and timing of product
   innovation can increase a firm’s market share.

Technological innovation and dynamics are
   positively related to a firm’s stock performance.

Patent activity has a negative impact on a firm’s
   short-term performance.

Production

Market value

228 small manufacturing firms in
  the West Midlands region
  of England

1101 new production introduction
   announcements by 231 firms

86 firms in the U.S. implantable
cardiac pacemaker industry

8851 firm-year observations

313 French biotech firms

in

Sales, employment,
   profitability,
   productivity, and
   exporting

Market value

Market share

Cumulative stock
   returns

Return on sales
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Hendricks and
New product introduction
   Singhal (2008)
		

Patent counts

Durand et al. (2008)

R&D intensity and
Market-to-book ratio
Over 91,000 observations
A firm’s market-to-book ratio is negatively related
   relative R&D intensity
   of firms listed in Compustat
   to its innovation strategy, but positively related
					
to its R&D intensity.

O’Brien (2003)

Feeny and Rogers (2003)

McWilliams and
R&D intensity
Accounting profits
524 firms
R&D intensity has a positive effect on financial
Siegel (2000)					
performance.

Return on assets

Return on capital

R&D spending

Capon et al. (1992)

Dependent variable(s)

Innovation measurements

Authors/study

Table 1. Studies on the Effect of Innovation on Organizational Performance
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Survey measures

Profitability-achieved
   rate

283 organizational units in a large
European financial service firm

101 commercial banks in four
   northeastern states in the
   United States

Sales

877 SMEs in Taiwan

184 Firms in the Beijing
   Experimental Zone

209 Finnish manufacturing firms

Terwiesch et al. (1998)
Survey measures
Return on sales
			

86 electronics business units in
12 industries

Perceived performance
Responses from 101 senior
managers		

The profitability of a business unit is negatively related
to its development intensity and positively related to its 		
  technical product performance. These relations vary
  with market context.

Radical innovation and incremental innovation are 		
positively related to innovation performance.

Oke (2007)
Survey measures
		

				

A firm’s business success is partially related to
   its development output performance.
Development expense intensity has a negative
   impact on profitability. Market leadership,
innovation rate, and product line freshness do
   not affect profitability and growth.

Survey measures

The linkage between innovation and performance
  is weak. Although administrative innovation has
a positive impact on sales, technological innovation, 		
marketing innovation, and strategic innovation do 		

Product innovation strategy has a positive
   impact on performance.

Product innovation has a negative effect on
   profitability, whereas process innovation has a
   positive effect on profitability.

Exploratory innovation and exploitative innovation
    do not have a direct impact on financial
    performance. Their effects are contingent on
environmental dynamism and competitiveness.

ROS, ROS growth,
95 international electronics
   sales growth
business units
				

Loch et al. (1996)

				
				
			
not have a direct impact on sales.

Survey measures

Lin and Chen (2007)

Net profit margin

A combined measure
of financial and
market performance

Survey measures

Li and
Survey measures
   Atuahene-Gima (2001)
		

Leiponen (2000)

				

Jansen et al. (2006)

			

Return on assets,  
  perceived
  effectiveness

of

Survey measures

The speed and number of innovation adoption
   contribute to a firm’s financial performance.
   Neither of the innovation dimensions influences
   how executives perceive the firm’s overall
effectiveness.

Innovation positively contributes to revenue
   growth.

Key findings/conclusions about the relationship
   between innovation and performance

Gopalakrishnan (2000)

845 Canadian manufacturing firms

Sample firms

Innovativeness has a direct positive effect
on performance and an indirect mediating
   effect on the relationship between quality and

Revenue growth

Dependent variable(s)

Growth, profitability,
488 firms in Fortune 1000
and market 		
   performance
			
performance.

New product introduction

Thornhill (2006)

Cho and Pucik (2005)
Survey measures
		

Innovation measurements

Authors/study

Table 1. Continued
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maker industry over a 31-year period, Banbury and
Mitchell (1995) observed that the more active a firm is
in pursuing product innovation, the greater the market
share it is likely to achieve.
Firms that strive to reach and maintain a high level
of innovativeness also often exhibit better economic
performance than less-innovative firms. By comparing four groups of Fortune 500 manufacturers, which
have different levels of research commitment, Capon
et al. (1992) found firms with the highest R&D spending enjoy greater profitability than the others. Roberts’s
(1999) longitudinal study of pharmaceutical companies
reveals that firms possessing the capacity to innovate
continuously over time are financially more successful.
Yet the available evidence is not always consistent (see,
e.g., Durand et al. 2008, Leiponen 2000, Loch et al. 1996,
Terwiesch et al. 1998). A recent study by Durand et al.
(2008) surprisingly shows that the number of patents a
firm owns has a depressing effect on its short-term performance. Terwiesch and his colleagues (Loch et al.
1996, Terwiesch et al. 1998) found that in the electronics industries, innovation-related development intensity
cuts down firm profitability.
Despite the general observation of the importance
of innovation, the specific underlying mechanisms of
the innovation process and its impact on operating efficiency are far less understood. It is not clear whether
the observed positive performance impact of innovation is caused by a rise of revenue associated with the
increased image of the firm in the market, or a reduction
in operating costs engendered by improved efficiency,
or both. Although there are a handful of studies that do
link innovation to sales, the results of these studies are
often weak and inconsistent. For example, using a survey of 877 small and medium sized firms in Taiwan, Lin
and Chen (2007) found that with the exception of administrative innovations, other forms of innovations do
not have an influence on company sales. Freel’s (2000)
study of new product introductions by 228 small manufacturing firms in England shows that although innovators enjoy higher employment growth and productivity,
they do not differ from non-innovators in terms of sales
growth, profitability, or export performance.
The mixed empirical evidence of the effect of innovation on firm performance is possibly due to the inadequacy of the measures adopted by previous studies. In
the section below, we briefly review some of the popular measures that have been applied in the literature.
3. Measures of Innovation
A variety of measures have been proposed and employed for analyzing the notion of innovation, includ-
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ing, among others, R&D spending, patents, and new
product introductions (see column 2 in Table 1). Although each of the available measures opens a window for studying innovation, none of them are above
criticism. For instance, there are a couple of shortcomings of R&D spending, one of the most commonly used
measures in the innovation literature. First, as an input
variable in the innovation process, R&D only reflects a
firm’s effort to carry out research programs, but it does
not necessarily indicate the firm’s innovation ability and
output (Kochhar and David 1996). In fact, firms with
the same amount of R&D spending may have substantially different innovation performance given the disparity of their abilities to organize, arrange, and integrate resources for knowledge creation. Second, the
requirement for R&D investment may vary markedly
from one industry to another. Balkin et al. (2000) empirically showed that high-technology firms are more
likely to provide incentives to induce CEOs to channel
resources to R&D projects as compared with their lowtechnology counterparts. The authors reasoned that, in
segments where knowledge is a key competitive factor
and changing rapidly, it is typically difficult, yet important, for firms to maintain a technological edge against
rivals. Under this condition, large expenditures in R&D
are desirable and conducive to firms. The variation in
firm practices and policies associated with the state of
market conditions thus makes it hard to meaningfully
compare R&D spending across industries.
Given the drawbacks of R&D spending, researchers
have turned to using patent data as an alternative approach. Unlike R&D spending, patents manifest some
outputs of the innovation process. Although this focus allows the instrument to get around some of the
problems inherent in R&D spending, patents also suffer a few limitations. Griliches (1990, p. 1666) explicitly
pointed out that “patents differ greatly in their technical and economic significance. Many of them reflect minor improvements of little economic value. Some of
them, however, prove extremely valuable.” Harhoff
et al.’s (1999) survey confirms this argument and shows
that, from the owner’s perspective, the value conveyed
by patents does diverge considerably. There is also evidence that the quantity of patents a firm owns does not
predict well firm value (LeVine 2010). These observations thus question the validity of using simple patent
counts as a proper indicator of innovation capacity.
In comparison, patent citations constitute a more sophisticated use of patent data. As a main advantage,
this approach offers a clear, objective way to guage and
control for the discrepancy in importance of patents by
weighting them according to how frequently they are
cited by others. However, like other patent-based measures of innovation, the citation index, too, focuses on
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innovations at the invention stage, but rarely on the
commercialization part of the innovation process. Furthermore, this index rests on the assumption that firms
pursue patent protection for all their innovations (Ziedonis 2004). Yet, the assumption of unselective patenting is questionable because patenting is not always necessary or desirable. In practice, firms may decide not to
patent their products, services, technologies, processes,
or business methods for confidentiality or growth considerations (Heeley et al. 2007, Kumar and Turnbull 2008).
Conversely, even if firms do file patent applications, they
may choose to do so for different motives. For example,
in industries where technology is complex—namely, innovation involves multiple complementary technological
components, patenting is commonly used to disrupt or
restrict rivals’ research agendas, to increase negotiation
power, and to create cross-licensing opportunities (Clark
and Konrad 2008, Heeley et al. 2007). In this context, the
value of patents is hard to be assessed and compared.
Moreover, recent studies have shown that a patent’s
citations may stem not only from its technological importance and viability but also from many other sources
like “publicity, licensing practices, interconnectedness, or
other technological features” (Rysman and Simcoe 2008,
p. 1925, also Rosenkopf and Almeida 2003, Singh 2005).
In other words, the justification of citations as an effective
proxy for patent quality may not be taken for granted.
Two other well-established measures in the field are
new product introductions and survey-based measures.
Proponents of the former approach hold that the rate
at which a firm introduces new products as well as the
radicalness of the products (i.e., whether they are new
to the firm, new to the market, or new to the world) signals the firm’s innovative ability. Nevertheless, innovation is not necessarily confined to product development;
rather, it could also relate to methods of production,
market expansion, sources of supply of raw materials,
and organization forms (Bantel and Jackson 1989, Goes
and Park 1997, Phene et al. 2006). In this regard, the
measurement of new product introductions is narrowly
focused. Survey instruments, by contrast, offer a more
general way to investigate innovation behaviors. These
tools are often flexible to be modified to fit different research settings and foci. They also allow direct data access from innovators and enable collection of detailed

7

information, which is usually not accessible through
other means or channels. However, survey measures are
self-reported. The reliance on subjective assessment of
organization members may lead to serious problems because what is perceived by the firm as highly innovative may be considered quite differently by the market.
In addition, the methodology itself is potentially subject
to the problem of common method bias.
Thus far, we have shown that it is difficult, if not impossible, to create a generalizable innovation measurement applicable to all organizations and circumstances.
That said, our intention is not to dispute the importance
of existing measures, such as those mentioned above;
their value and contributions have already been recognized in the literature. From a practical standpoint, all
these measures provide reasonable ways to test innovation-related phenomenon, although each of them reveals only part of the complete picture. Given the richness of the notion of innovation, we contend that a
diversity of measurements is necessary and beneficial
to the development of the field. For example, innovation
awards could represent a useful complement to patents
and patent citations, given their properties and selection
mechanisms. Although patents and patent citations are
reasonable indicators of the output mainly from the invention part of the innovation process, the use of innovation awards can provide a more direct measure of effective innovation because of the clear focus of award
givers on the commercial application of new products
or services. Table 2 provides a detailed comparison of
major innovation measures.
4. Hypotheses
Award-winning innovations are non-trivial ones. They
tend to be influential in the sense that their adoption
and application can have a significant impact on business trend, customer choice, or the way firms compete
in the market. Winning an innovation award reflects a
firm’s commitment to highly innovative programs, as
well as how successfully these programs have been implemented. Although innovation is conducive to firms
(Hull and Rothenberg 2008, Roberts 1999, Thornhill
2006), the benefits of undertaking effective innovation

Table 2. Comparison of Innovation Measurements
Innovation measurements

Innovation awards

R&D spending

Patents

New products

Survey

Input vs. output
Development stage
Scope of innovation
Subjective vs. objective
High-impact vs. minor innovations

Output
Commercialization
Broad
Objective
High-impact innovations

Input
Mostly invention
Unclear
Objective
Unclear

Output
Invention
Broad
Objective
Both

Output
Commercialization
Narrow (products)
Objective
Both

Both
Both
Broad
Subjective
Both
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programs may be even greater given the quality of the
outputs of such programs. Hence, innovation award
winners should be able to distinguish themselves financially from peer firms that are not honored by such
awards. In keeping with prior research (Cho and Pucik
2005, Roberts 1999), we measure profitability by return
on assets (ROA), which is income before extraordinary
items4 divided by total assets, and return on sales (ROS),
which is income before extraordinary items divided by
net sales. As it is likely that a firm’s profitability is affected by its choice of depreciation method, we also use
operating income (which is before depreciation) as an
alternative measure of profitability.
Hypothesis 1. Conducting an effective innovation program will increase a firm’s profitability.
It is important to note that although analogous hypotheses have been tested in prior research, Hypothesis
1 is worth studying for its own sake. In fact, most of the
past work has focused on R&D spending, new product
introduction, and patents, which have limitations as we
have noted above. In addition, recent research shows
that innovations are dissimilar in terms of their impact
and utility (Govindarajan and Kopalle 2006, Phene et al.
2006). Unlike their major counterparts, minor innovations only confer limited benefit to firms, whose value
tends to evaporate quickly.5 Indeed, Roberts and Amit
(2003) found that just being the first to adopt an innovation does not naturally bring a competitive advantage
to a firm. In this light, a holistic approach of aggregating all innovations may not be ideal as this may obscure
the effect of those larger, more influential ones. Despite
the conceptual importance of high-impact innovations
(Schumpeter 1934), no empirical study to date has specifically examined how these innovations may contribute to firms and what the magnitude of their impact
would be. Innovation awards help weed out low-impact
innovations and thus offer an avenue to fill the void.
Hypothesis 1 establishes a baseline hypothesis, yet
the relationship between innovation awards and profitability could be more elaborate and complex than it
appears. First-mover advantage theorists (Lieberman
and Montgomery 1988, Song et al. 1999) posit that innovation-related activities can promote a company’s
brand image and visibility. As a result, firms that are
active in innovation can charge premium prices by influencing the way consumers perceive the value of
their products or services. The anticompetition perspective (Roberts 1999) arrives at a similar conclusion
from a different angle. Anchored in industry organization economics, this view speculates that innovations
can function as a critical means of deterring rival en-
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try. On one hand, participating in innovation can foster
knowledge creation, which allows firms to use patents
to protect their market positions; on the other hand,
such activity can strengthen customer loyalty, making it more costly and less beneficial for other firms
to compete in the same market. Together, these arguments suggest that innovation may generate higher
revenue for the firm. We expect that the magnitude of
this benefit would be more significant and notable for
firms with a more effective innovation program. We
use net sales to measure revenue.
Hypothesis 2. Conducting an effective innovation program will increase a firm’s revenue.
An award-winning innovation program may render
a cost benefit as well. According to the competence renewal perspective on innovation (Danneels 2002), innovation could serve as an important vehicle for organizational learning and renewal. This argument is consistent
with the theory of dynamic capabilities and the literature on absorptive capacity (Cohen and Levinthal
1990, Teece et al. 1997), both of which posit that firms
are evolving systems and can constantly update their
knowledge and skills. By definition, innovation implies
a deviation from conventional course of behaviors. To
be productive in this effort, firms need to question their
own assumptions and premise of existing practices. This
process forces firms to think about new ways of combining resources and re-link knowledge components,
which creates opportunities for improving operational
efficiency. Innovation also puts a demand on coordination among separate units within the firm (Danneels
2002). Hence, an effective award-winning innovation
program could facilitate inter-unit communication and
idea exchange, accelerating knowledge sharing and integration. As a consequence, new technologies or skills
may emerge, which can improve product quality, reduce defects, streamline manufacturing process, and
lower production costs (Cho and Pucik 2005, Lieberman
and Montgomery 1988). We follow Hendricks and Singhal (1997b) to use cost per dollar of sales, defined as the
sum of cost of goods sold plus selling, general, and administrative expenses divided by net sales, as a measure
of operating cost.
Hypothesis 3. Conducting an effective innovation program will reduce a firm’s operating costs.
The benefits of effective innovation programs mentioned above should open up to firms with more growth
opportunities. Hence, we expect award-winners to have
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a higher financial market valuation than other firms. We
use Tobin’s Q as a measure of a firm’s market valuation
and growth potential. It is calculated as the ratio of the
market value of a firm’s debt and equity to the current
replacement cost of its assets (Corbett et al. 2005).
Hypothesis 4. Conducting an effective innovation program will increase a firm’s Tobin’s Q.
5. Methodology
5.1. Data Collection
The first step in the data collection process was to obtain a comprehensive list of firms that had won innovation awards between 1998 and 2003. Our primary source
for identifying such firms is the Dow Jones Factiva, an
online search database containing news sources from
Associated Press, Business Wire, Dow Jones News Service, Financial Times, PR Newswire, and the Wall Street
Journal. We performed a search using various combinations of key words, such as award, innovation, innovative, design, creative, original, and new product (service). This resulted in over ten thousand press releases
or news articles, each of which was read to determine
and cross-verify whether firms had actually won innovation awards and, if so, the timing of the award. Some
examples of press releases are given below.
● “Aspen Technology, Inc., the leading provider of
Smart Manufacturing and Supply Chain Management software and services for the process industries, today announced it has received the Industry Week Technology of the Year award.” Business
Wire, Dec. 22, 1998.
● “NMS Communications, a leading supplier of technology for tomorrow’s networks, today announced
that its Packet Media IP media server development
platform has won the Product of the Year award
presented by Internet Telephony Magazine.” Business Wire, December 19, 2000.
● “Jasc Software, Inc. today announced that it received
the CNET Editors’ Choice award for its Paint Shop
Photo Album 4. CNET Editors’ Choice winners are
recognized as top products in their respective technology categories, and contribute to the standard
by which all future products are judged. A key selection requirement is the difference it makes in the
lives of its users, whether through innovative features, exceptional value for the price, remarkable
ease of use, or a demonstrable boost to users’ productivity.” PR Newswire, March 14, 2003.
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A total of 6219 distinct award-winning firms were
found from this initial search.
The financial and accounting data for these firms
were then retrieved from COMPUSTAT. Among the
6219 firms, 1141 firms were listed on the COMPUSTAT
database. These firms represent a wide range of industries in both the manufacturing and service sectors. Table 3a depicts the distribution of the sample firms by
year. From 1998 to 2003, the percentage of firms in the
sample generally increases from 6.5% to nearly 30%.
Table 3b shows the distribution of the sample firms by
2-digit SIC code. The sample firms are fairly well represented across different industries. The highest concentration is in manufacturing (593 firms, 52%) and
services (341 firms, 30%), and the lowest is in construction (5 firms), public administration (5 firms), and mining (9 firms).
The performance metrics used in this study include
operating income, sales, ratio of total cost to sales, Tobin’s Q, and return-based measures, such as ROA and
ROS. These variables have been widely used in the
strategy and operations management literatures (e.g.,
Cho and Pucik 2005, Corbett et al. 2005, Hendricks et al.
2007), and reflect different aspects of the outcome of
business operations, that is, profitability, revenue, cost
efficiency, and market value.
Table 3a. Distribution of Sample Firms by Year
Year

Frequency

Percent

1998
1999
2000
2001
2002
2003
Total

74
112
175
222
219
339
1141

6.49
9.82
15.34
19.46
19.19
29.71
100.00

Table 3b. Distribution of Sample Firms by 2-Digit SIC Code
SIC Code

Industry

Frequency

Percent

10–14
15–17
20–39
40–49

Mining
Construction
Manufacturing
Transportation,
Communications,
Electric, Gas, and
Sanitary Services
Wholesale Trade
Retail Trade
Finance, Insurance,
and Real Estate
Services
Public Administration

9
5
593
81

0.79
0.44
51.97
7.10

26
35
46

2.28
3.07
4.03

341
5

29.89
0.44

1141

100

50–51
52–59
60–67
70–89
91–99

Total
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We tracked a firm’s performance change over an
8-year period because the effect of an innovation program may not be able to manifest in a short time, especially for those award winners whose winning products and services are new to the market. Specifically, the
evaluation period starts 4 years before and ends 3 years
after the year when the firm received its first innovation
award. Similar pre- and post-implementation time periods have been used in several other studies, such as
Corbett et al. (2005) and Hendricks et al. (2007). To pool
observations over time, we translated the calendar year
to an event year for each firm, with year 0 being defined
as the year the firm received the award, year ±1 as the
year after/before the award, year ±2 as the second year
after/before the award, and so on.
5.2. Control Firm Selection
To examine the benefits of an award-winning innovation program, it is critical to compare the performance
of award-winning firms with that of a group of carefully
chosen control firms. The purposes of using the control
group are to provide a benchmark for the performance
of the sample firms and to control for potential industry
and/or economy-wide effects on a firm’s performance
that may have nothing to do with innovation effectiveness. An ideal control firm would be the one that is identical to the sample firm in every aspect of business, except that it has not won an innovation award. Such an
ideal firm, however, does not exist. Hence, control firms
are commonly selected to match sample firms as closely
as possible in several key dimensions, such as industry,
size, and pre-event performance (Corbett et al. 2005, Hendricks et al. 2007). Total assets are often used as a proxy
for firm size, whereas the ROA6 is a preferred measure of
performance in choosing control firms (Barber and Lyon
1996, Corbett et al. 2005). In innovation research, the R&D
spending or intensity is often found to be an important
factor that can influence the innovation outcome and it
can vary widely among firms even in the same industry.
Barber and Lyon (1996) find that matching by firm size in
addition to industry and ROA provides little or no extra
benefit. Therefore, we used the R&D intensity (defined
as the ratio of R&D spending to sales) instead of the firm
size as one of the criteria to identify control firms. Thus,
a control firm in our study is the one in the same industry that is closest to the award-winning firm in ROA and
R&D intensity. In addition, although one-to-one matching is common in the literature, using a matching portfolio of similar firms often yields more powerful test statistics (Alderson and Betker 2005). Therefore, we considered
both one-to-one and one-to-portfolio matching methods
in this study. In all cases, the year proceeding the award
year was used as the basis to select control firms.
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Following Corbett et al. (2005), we used the following
steps to select control firms:
● Inside the same 2-digit industry of each sample firm,
we identify control firms whose ROA is within 90%
and 110% times ROA of the sample firm and whose
R&D intensity is within 0.7 and 1.3 times the R&D
intensity of the sample firm.
● In one-to-one matching, we first calculate for each
firm the z-scores for ROA and R&D intensity (defined as the ratio of the difference between the
ROA [R&D intensity] and the industry mean to
the industry standard deviation), and then compute the Euclidean distance in the two-dimensional space of z-scores. The matching firm is the
one whose Euclidean distance is closest to that of
the sample firm.
● In one-to-portfolio matching, all the firms identified
in step (1) are chosen as the control firms.
● If for some sample firms, no control firms could be
identified in (1), the industry is relaxed to a onedigit SIC and then the procedure is repeated.
5.3. Abnormal Performance Measure and Analysis
We first employ the event-study method to assess the
abnormal performance of award-winning firms. Like
other studies using the same approach (e.g., Hendricks and Singhal 1997b, Hendricks et al. 2007), we
define a sample firm’s abnormal performance as the
percentage change in the firm’s performance minus
the percentage change in the control firm’s performance. More specifically, we calculate the abnormal
performance measure as
PMSt1 – PMSt2
PMSt2

–

PMCt1 – PMCt2
PMCt2

where PMSt1 (PMCt1) is the performance measure for
the sample (control) firm in year t1 and PMSt2 (PMCt2) is
the performance measure for the sample (control) firm
in year t2.
To control for the effect of potential outliers, all abnormal performance measures are trimmed symmetrically at the 2.5% level in each tail. Even with the trimming, the data may still not be symmetric and outliers
may still be an issue. For this reason, we report both
parametric and non-parametric testing results. The
parametric test is based on the normal t-test on changes
in the mean, and the non-parametric test we employed
is the Wilcoxon signed-rank (WSR) test. These tests are
used to analyze whether the median of the changes is
significantly different from zero. It is important to note
that because of the matching requirements, the missing
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of data for calculation, and the data trimming, the sample sizes actually used in the event study analysis vary
depending on which performance metric is used and
what time interval is considered.
5.4. Panel Regression Analysis
Although our choice of the event-study method is motivated and justified by earlier research with a similar interest in quality awards and certifications (Corbett et al.
2005, Hendricks and Singhal 1997b), firms’ R&D activity can vary over time rather than being static as assumed by the event-study approach.7 For this reason,
we also conducted panel data analysis. Specifically, we
used two-way fixed effects models to control for sources
of unobserved heterogeneity. This approach also accounts for possible non-independence of observations
that share the same sources of variance. The basic model
form can be written as:
PM =  R&D + β Award Dummy
+ γ R&D × Award Dummy

+ Σi θi Control Variablei + Error

where PM represents the performance measure variable,
such as ROA; R&D is the R&D intensity; AwardDummy
is the award winning dummy variable; , β, γ, and θ represent model coefficients. The model directly builds up
the relationship between the inputs and outputs of innovation program with the award winning dummy serving as a moderator. The coefficient on the interaction between R&D and AwardDummy should capture the extra
returns to R&D investment for award-winning firms.
We considered a number of control variables at both
the firm and industry levels. The natural logarithm of
total sales was included to account for firm size. Strategic alliance formation could affect firm performance one
way or another (Stuart 2000, Yu et al. 2011). Thus, we
included in the model an alliance variable, which was
coded as the total number of alliances formed by a firm
in a 5-year window8 preceding each observation year.
Alliance data were obtained from the Securities Data
Company (SDC) database. A Herfindahl index of diversification was used in our analysis to capture the potential diversification effect as predicted by previous research (e.g., Rumelt 1982). In addition, we controlled for
financial leverage, plant and equipment (P&E) newness,
and capital intensity. Financial leverage was measured
as total debt divided by total assets. P&E newness was
measured as new P&E divided by gross P&E. Capital
intensity was calculated as the ratio of the net value of
property, plant, and equipment to net sales.
To control for possible industry effects on firm performance, we further included two industry variables: in-
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dustry attractiveness and technology opportunity. The
industry attractiveness variable was approximated by
the mean of the ratio of operating profit to sales in each
industry. Technology opportunity was measured by the
mean industry R&D intensity. In addition to above firm
level and industry level factors, we also included year
and firm dummy variables. These dummies were used to
account for the unobserved time and firm differences.
All independent variables and control variables were
lagged to minimize the possibility of reverse causation.
We estimated models using 1-year lags for all control
variables while using either 1-year lag or 3-year lag for
R&D intensity to test for its short-term or long-term effects. The time period chosen for the analysis was from
years −1 to +3.
6. Empirical Results
6.1. Results from the Event Study Analysis
We first present results from the event study analysis.
Because of the similarity in results between one-to-one
matching and one-to-portfolio matching, we report here
only the results from the one-to-one matching method.
Table 4 shows summary statistics for award-winning
firms and control firms at t − 1.
For each performance measure, we report two sets of
results. The first is the mean and median of the annual
difference in the percentage change in performance between the sample and control firms. These results show
the year-to-year performance change in the award-winning firms relative to control firms. The second set of
results report the mean and median of the percentage
difference in performance between the sample and control firms over several longer time intervals, such as between years −1 and +1, −1 and +2, −1 and +3, and −4
and +3 to reflect different patterns of change in performance across firms (see Hendricks and Singhal [1997b]
for a discussion on using different time intervals to detect changes of performance over time).
Table 5 reports the mean and median changes on
three return/profitability measures when the control
firms are selected based on matching on industry, ROA,
and R&D intensity. Panel A of the table shows the control adjusted changes on an annual basis over the 8-year
period starting from year −4 and ending in year +3,
whereas Panel B gives the results on several longer periods reflecting the changes from 1 year and 4 years before the innovation award to 1, 2 and/or 3 years after
the award. Panel A shows that the annual mean and median changes in ROA and ROS are all positive and significant at the 10% level in most years. It also shows that
on an annual basis, both the mean and median changes
in operating income of the award-winning firms are
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Table 4. Descriptive Statistics for the Sample Firms and Control Firms Using One-to-One Matching by Industry, ROA, and R&D intensity
 	
Sample Firms
ROA (%)
ROS (%)
Operating Income (million $)
Sales (million $)
Cost/Sales (%)
Tobin’s Q
Control Firms
ROA (%)
ROS (%)
Operating Income (million $)
Sales (million $)
Cost/Sales (%)
Tobin’s Q

Obs

Mean

Median

SD

Minimum

Maximum

360
360
493
493
440
440

3.81
3.88
269.78
1443.06
94.99
2.11

4.61
4.87
4.98
112.95
90.04
1.30

0.09
0.11
1469.64
7015.81
22.09
2.40

−28.03
−28.65
−337.59
0.12
43.43
0.03

27.78
40.78
19276.00
81186.00
295.87
15.05

360
360
493
493
440
440

3.75
3.12
199.60
1190.05
96.23
1.80

4.62
4.40
4.70
95.70
90.53
1.30

0.08
0.10
1113.03
5901.70
23.92
1.79

−28.41
−34.95
−193.11
0.11
45.27
0.02

26.33
34.54
18632.00
72944.00
424.59
11.19

Table 5. Mean and Median Control Adjusted Percentage Changes in ROA, ROS, and Operating Income with Control Firms Selected by Industry,
ROA, and R&D Intensity
ROA

ROS

Operating income

					
WSR 					
WSR 					
WSR
From year
Obs Mean Median T-test
test
Obs Mean Median T-test
test
Obs Mean Median T-test
test
Panel A: Changes in Performance on an Annual Basis
−4 to −3
165
8.16
7.25 0.218
−3 to −2
154 30.57 14.65 0.098
−2 to −1
181 12.18 13.29 0.083
−1 to 0
206 20.30 14.34 0.093
0 to +1
140 20.80 11.90 0.094
+1 to +2
107 18.98 13.49 0.027
+2 to +3
112 28.71 15.25 0.098

0.609
0.086
0.090
0.098
0.081
0.081
0.067

165
156
174
203
143
106
120

9.03
37.88
14.19
22.27
21.68
17.41
33.62

7.44
17.24
8.86
19.55
11.05
8.85
11.45

0.224
0.098
0.072
0.084
0.090
0.053
0.096

0.519
0.056
0.055
0.091
0.086
0.090
0.093

220
242
220
224
176
168
164

7.90
15.30
22.35
12.05
24.34
15.00
15.60

2.21
10.51
14.75
12.03
11.53
8.29
10.17

0.237
0.009
0.001
0.007
0.023
0.023
0.027

0.894
0.006
0.008
0.016
0.069
0.091
0.297

Panel B: Changes in Performance Over Varying Time Periods
−1 to +1
205 30.07 16.90 0.097 0.057
−1 to +2
191 33.96 11.16 0.051 0.046
−1 to +3
177 32.43 18.97 0.039 0.042
−4 to +3
112 32.56 23.53 0.010 0.033

215
189
175
115

33.01
29.27
34.38
34.54

10.70
7.00
23.23
24.11

0.097
0.095
0.061
0.006

0.075
0.080
0.031
0.027

229
184
175
150

12.94
15.28
18.95
39.11

11.90
17.56
21.70
36.18

0.058
0.077
0.090
0.063

0.062
0.097
0.228
0.089

positive and significant at the 5% level in the majority
of cases. Over the longer time intervals, Panel B shows
that the mean changes in ROA, ROS, and operating income are all positive and significant in nearly all cases.
For example, from years −4 to +3, the award-winning
firms have, on average, about 32.6% higher ROA, 34.5%
higher ROS, and 39.1% higher operating income than
the corresponding control firms. The median changes
in these measures, although still significant at the 5% or
10% level, have relatively smaller values than the mean
changes. Overall, the results provide strong evidence
that the returns on investment for the test firms are significantly higher than for the control firms.
Table 6 reports the control adjusted changes in sales,
total cost/sales, and Tobin’s Q over one-year period
(Panel A) and over longer time periods (Panel B) when
the control firms are selected by matching on industry,
prior performance, and R&D intensity. Panel A shows
that on an annual basis, both the mean and median
changes in sales of the award-winning firms are positive

and significant (p < 0.05) in almost all intervals. For the
ratio of total cost to sales, the mean changes are negative
and significant at the 10% level in all years except from
year 0 to +1. The median changes are negative and significant at the 10% level only at years −1 to 0 and +2 to
+3. The annual mean change in Tobin’s Q is positive in
all years except from year −4 to −3, but is only highly
significant at the 1% level for years from +2 to +3, and
significant at the 10% level from years −3 to −2, −2 to −1,
and −1 to 0. The annual median change is only significant at the 5% level for years +2 to +3.
From 1 year before to 1, 2, and 3 years after winning
an award, Panel B of Table 6 shows that the mean (median) changes in sales are positive and significant at the
1% (10%) level. For the cost per dollar of sales and Tobin’s Q, the mean changes are significant (p < 0.05 or
0.10) for all three time intervals, but the median changes
are not. Over the 8-year period from years −4 to +3, the
mean (median) control adjusted change in sales is about
39.3% (20.7%). Over the same period of time, the mean
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Table 6. Mean and Median Control Adjusted Percentage Changes in Sales, Cost, and Tobin’s Q with Control Firms Selected by Industry, ROA,
and R&D Intensity
Sales

Total cost/sales

Tobin’s Q

					
WSR 					
WSR 					
WSR
From year
Obs
Mean Median T-test
test
Obs
Mean Median T-test
test
Obs
Mean Median T-test
test
Panel A: Changes in Performance on an Annual Basis
−4 to −3
373
6.05
2.52
0.004
−3 to −2
407
8.60
6.17
0.000
−2 to −1
448
7.43
4.26
0.000
−1 to 0
457
11.78
6.63
0.000
0 to +1
371
4.73
0.00
0.001
+1 to +2
344
2.88
1.91
0.017
+2 to +3
314
4.72
3.28
0.001

0.026
0.001
0.000
0.000
0.234
0.069
0.014

378
401
426
432
368
312
223

−2.44
−1.74
−1.39
−1.57
0.68
−1.79
−2.81

−0.03
−0.96
−0.92
−1.44
1.03
−0.56
−1.90

0.016
0.045
0.077
0.049
0.187
0.008
0.003

0.567
0.103
0.259
0.056
0.273
0.260
0.009

194
216
195
194
190
162
172

−2.71
8.00
6.69
8.02
1.27
5.53
9.49

−1.34
4.04
8.39
4.43
1.75
4.50
7.15

0.298
0.073
0.078
0.068
0.379
0.127
0.002

0.546
0.271
0.240
0.409
0.680
0.696
0.017

Panel B: Changes in Performance Over Varying Time Periods
−1 to +1
405
9.45
3.83
0.001
0.063
−1 to +2
361
12.40
5.22
0.002
0.093
−1 to +3
317
21.76
8.78
0.000
0.013
−4 to +3
239
39.28
20.71
0.004
0.069

353
324
262
216

−1.51
−2.38
−2.23
−5.52

−1.59
−1.05
−2.28
−3.80

0.070
0.014
0.057
0.002

0.152
0.108
0.263
0.027

147
107
96
91

12.76
18.72
16.52
23.70

6.65
13.88
10.17
3.16

0.049
0.017
0.052
0.020

0.184
0.086
0.172
0.197

Table 7. Mean and Median Control Adjusted Percentage Changes in ROA, ROS, and Operating Income with Control Firms Selected by Industry,
Percentage Change in ROA, and Percentage Change in R&D Intensity
			
ROA					
ROS			
Operating Income
					
WSR 					
WSR 					
WSR
From year
Obs
Mean Median p-value
test
Obs
Mean Median p-value
test
Obs
Mean Median p-value
test
Panel A: Changes in Performance on an Annual Basis
−4 to −3
126
9.23
4.07
0.364
−3 to −2
111
27.51
21.76
0.097
−2 to −1
101
0.60
0.76
0.278
−1 to 0
107
23.29
22.41
0.069
0 to +1
82
19.82
11.19
0.326
+1 to +2
72
28.60
22.39
0.121
+2 to +3
75
33.75
26.08
0.092

0.972
0.095
0.484
0.157
0.409
0.228
0.042

125
109
103
110
81
74
74

15.60
26.88
6.58
27.53
19.83
34.91
30.76

9.85
14.27
2.94
13.78
6.76
23.98
17.83

0.290
0.185
0.063
0.068
0.328
0.046
0.069

0.772
0.057
0.050
0.021
0.276
0.081
0.058

187
181
183
149
123
110
110

13.99
11.46
17.14
14.54
17.38
16.73
17.52

2.94
10.21
10.57
16.18
6.30
9.96
16.88

0.059
0.059
0.009
0.084
0.053
0.076
0.026

0.439
0.031
0.027
0.041
0.123
0.093
0.025

Panel B: Changes in Performance Over Varying Time Periods
−1 to +1
84
32.13
20.60
0.072
0.072
−1 to +2
79
42.60
33.27
0.050
0.078
−1 to +3
70
52.26
38.42
0.009
0.009
−4 to +3
70
55.40
45.53
0.011
0.023

84
80
70
74

34.98
39.16
44.06
78.37

26.44
31.66
31.61
42.59

0.067
0.041
0.015
0.001

0.076
0.091
0.025
0.002

125
112
93
99

21.31
38.71
49.11
51.17

15.41
14.71
15.99
19.10

0.131
0.023
0.016
0.043

0.037
0.070
0.074
0.099

(median) change in cost per dollar of sales of the sample firms is 5.5% (3.8%) lower than that of the control
firms. These changes are significant at the 5% level. In
addition, the award-winning firms have about 23.7%
(3.2%) higher Tobin’s Q than the control firms in control
adjusted mean (median) with the difference significant
at the 5% (10%) level.
We have also conducted an extensive set of sensitivity analyses based on different groups of control firms
selected with different matching criteria. First, our selection of control firms was based on the firm performance and characteristics in the year before the award
year. Although this is the standard practice in the literature, the results may be biased because the matching
does not consider the temporal change in firm performance. Award-winning firms may have higher percentage change in performance compared with the control
firms before winning the awards, thus carrying that mo-

mentum into the future. To rule out this possibility, we
ran analyses based on control firms selected with similar percentage changes in ROA and/or R&D intensity
from year t − 2 to year t − 1 . The results, as shown in
Tables 7 and 8, are quite similar.
Second, we used the ROA as the measure of performance in choosing control firms. Although matching
based on ROA is an accepted approach, we considered
other performance measures, such as operating income,
ROS, sales, and total costs as the basis for the selection
of control firms. The results are largely unchanged from
our main results reported earlier and are not reported
here due to the similarity.
Third, although we define the abnormal performance
measure as the percentage change in financial performance between a sample firm and its control firm at two
different time periods, abnormal performance can also be
defined as a simple change in the performance of a sam-
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Table 8. Mean and Median Control Adjusted Percentage Changes in Sales, Cost, and Tobin’s Q with Control Firms Selected by Industry,
Percentage Change in ROA, and Percentage Change in R&D Intensity
Sales
					
WSR
From Year
Obs
Mean Median p-value
test

          Total cost/sales
Tobin’s Q
				
WSR 					
WSR
Obs
Mean Median p-value
test
Obs
Mean Median p-value
test

Panel A: Changes in Performance on an Annual Basis
−4 to −3
316
12.47
5.28
0.002
−3 to −2
352
17.92
6.03
0.000
−2 to −1
378
13.12
7.91
0.000
−1 to 0
353
10.74
7.15
0.000
0 to +1
265
6.09
4.29
0.005
+1 to +2
205
5.99
6.20
0.001
+2 to +3
201
6.72
7.22
0.001

0.012
0.000
0.000
0.000
0.005
0.001
0.003

286
314
346
312
253
208
216

−0.94
−1.96
−3.00
−1.94
−1.49
−3.23
−2.58

−0.02
−1.00
−1.68
−0.41
−1.10
−0.82
−0.86

0.198
0.044
0.000
0.009
0.080
0.000
0.001

0.955
0.328
0.003
0.074
0.340
0.001
0.020

148
168
150
154
123
115
99

5.66
8.15
9.54
11.54
7.49
9.08
9.17

−6.37
2.81
2.75
11.25
1.12
6.77
8.57

0.190
0.128
0.102
0.066
0.147
0.079
0.063

0.660
0.961
0.884
0.252
0.385
0.269
0.090

Panel B: Changes in Performance Over Varying Time Periods
−1 to +1
275
12.63
13.66
0.003
0.009
−1 to +2
210
20.07
18.46
0.001
0.000
−1 to +3
206
26.41
20.98
0.002
0.014
−4 to +3
167
63.57
33.58
0.009
0.065

247
204
184
146

−2.08
−2.06
−2.77
−3.52

−2.34
−2.88
−3.33
−2.96

0.063
0.091
0.041
0.030

0.200
0.065
0.093
0.095

114
87
70
66

14.42
17.91
21.54
19.36

16.32
8.59
10.15
3.93

0.078
0.009
0.015
0.152

0.463
0.057
0.035
0.972

ple firm relative to that of the control firm. To check the
robustness of our results to the different ways to calculate
abnormal performance measures, we reran the analyses
and found the results do not change qualitatively.
Finally, based on other popular ways of choosing control firms discussed in the literature, we have also run the
analysis by selecting control firms by industry, firm size,
and ROA, and by industry and ROA without considering
the R&D intensity. Results from these additional analyses
are again similar to those reported earlier.
An alternative explanation to our findings is that,
rather than a signal of effective innovation programs,
innovation awards may in themselves create value to
firms. In other words, receiving innovation awards may
substantially improve customer perception of the firm,
leading to a reputational effect. While this mechanism
may exist, our finding that award-winners continuously
had better performance even before the announcements
of the awards suggests that our results are more likely to
be an outcome of well-designed innovation programs.
6.2. Results from the Panel Regression Analysis
Tables 9 and 10 provide the panel regression results. Table 9 shows results from short-term models with 1-year lag
for R&D intensity, whereas Table 10 shows results of longterm models with 3-year lags for R&D intensity. Models
1–6 in both tables report results for each of the six performance measures used as the dependent variable. For all
models, we checked the variance inflation factors (VIFs)
and found that none of them was greater than 4, indicating that multicollinearity is not a big concern in our study.
Results in Table 9 show that in the short term, R&D intensity significantly decreases the firm profitability in ROA
and ROS (Models 1 and 2), largely due to its negative effect on cost as shown with Model 5. R&D intensity, how-

ever, does not affect operating income, sales, and Tobin’s
Q in a significant way. On the other hand, award dummy
is highly significant (p < 0.001) in all six performance models, suggesting that winning an innovation award does
contribute to improved firm performance. The interaction
effect between R&D intensity and award winning is positive and highly significant in models on ROA and ROS.
This indicates that besides its direct impact, an effective innovation program can also indirectly influence firm performance by streamlining R&D spending.
These findings are robust when we look at the results
from the long-term models reported in Table 10. For example, award dummy is highly significant (p < 0.01) in
all performance models except the Model 6 for Tobin’s
Q. There is a significant positive interaction effect between R&D intensity and award dummy for Models 1
and 2, again showing the higher returns of award-winning firms. Interestingly, while R&D intensity negatively affects ROA and ROS in the short term, its effect
on the financial returns is positive and significant in the
longer term models, suggesting the possible lagged effect of R&D expenditures on firm performance.
The coefficients for the control variables are generally
consistent with the existing literature. We observe that
although larger firms can generate more revenue than
smaller firms, there is a negative firm size effect on profitability and market value. This supports the argument that,
as firms grow larger, they become more ossified and less
adaptive, leading to a lower firm performance (Haveman
1993). We find alliance connections reduce operating costs
and increase profitability. This can be explained by the fact
that interfirm collaboration allows firms to share cost of
new product development and access to complementary
assets owned by their partners (Powell 1990). Moreover,
P&E newness is negatively related to profitability. This
finding can be attributed to increased operating costs.

0.52

Adjusted R square

Standard errors are in parentheses.
ROA = return on assets; ROS = return on sales.
† p < 0.10 ; * p < 0.05 ; ** p < 0.01 ; *** p < 0.001

0.65

2975

Yes

Year dummies

R square

N

Yes

Firm dummies

R&D intensity × Award dummy

0.0308*** (0.0073)

0.6264*** (0.1375)

Award dummy

Interaction effects

−0.0285*** (0.0043)

R&D intensity

0.59

0.70

2977

Yes

Yes

0.3017*** (0.0364)

2.6718*** (0.5561)

−0.1949*** (0.0208)

−0.0178 (0.0114)

−0.0013 (0.0026)

Technological opportunity

Direct effects

1.0231 (0.6372)
−0.0158 (0.0103)

0.0608 (0.1404)
−0.0009 (0.0023)

0.1758 (0.1187)
−2.4474*** (0.3981)

0.0403 (0.0258)
−0.4008*** (0.0919)

Industry attractiveness

Capital intensity

P&E newness

Debt/total assets

5.3634 (6.9475)

0.1135*** (0.0306)

0.0154* (0.0066)

Alliance
−0.3111 (1.5825)

−0.1416* (0.0677)

Diversification

−1.6834** (0.5761)

0.4691*** (0.1392)
−0.0939*** (0.0164)

Firm size

Model 2
ROS

Intercept

Controls

Model 1
ROA

0.0439 (0.0692)

0.83

0.88

2964

Yes

Yes

0.0027 (0.0213)

18.0368*** (0.5771)

0.0068 (0.0120)

0.0020 (0.0067)

−0.0077 (0.0059)

0.4634 (0.3833)

−0.1855 (0.2408)

0.78

0.84

2977

Yes

Yes

0.0569 (0.1437)

33.9740*** (1.8378)

0.0901 (0.0817)

−0.0540 (0.0468)

−0.0197 (0.0406)

22.3692*** (2.4705)

−13.6393*** (1.5686)

1.5199*** (0.4524)

50.8878*** (13.7436)

−1.1626*** (0.1105)

−0.4347*** (0.0204)
37.3137*** (3.8515)

6.4556*** (0.2449)

−17.2708*** (2.3501)

Model 4
Sales

0.2491*** (0.0470)

−2.4687*** (0.3984)

Model 3
Oper income

0.0024 (0.0682)

0.72

0.80

2600

Yes

Yes

−0.0024 (0.0352)

−0.6634*** (0.0863)

0.0970*** (0.0156)

0.0008 (0.0012)

−0.0002 (0.0010)

0.50

0.64

2711

Yes

Yes

−0.1206 (0.1016)

3.3856*** (0.8796)

−0.0636 (0.0419)

0.0182 (0.0176)

0.0106 (0.0148)

−1.3603 (0.9315)

1.7952** (0.6324)

−0.8360*** (0.1582)

−0.0233† (0.0121)
0.2137*** (0.0417)

−23.9985* (10.4319)

0.2233*** (0.0427)

−2.0201*** (0.1002)

15.8414*** (1.0336)

Model 6
Tobin’s Q

−0.2827 (0.6730)

−0.0065** (0.0025)

−0.0100 (0.0086)

1.4756*** (0.0799)

Model 5
Cost/sales

of
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−0.9476 (1.3154)
−0.0097 (0.0134)
−0.0188 (0.0179)

−1.2425*** (0.3287)
−0.0005 (0.0034)
−0.0016 (0.0046)

Capital intensity

Industry attractiveness

Technological opportunity

0.46

Adjusted R square

Standard errors are in parentheses.
ROA = return on assets; ROS = return on sales
† p < 0.10 ; * p < 0.05 ; ** p < 0.01 ; *** p < 0.001

0.71
0.49

0.73

1400

Yes

Yes

0.79

0.89

1398

Yes

Yes

−0.0046 (0.0735)

5.6371*** (0.6040)

0.0185 (0.0424)

0.83

0.90

1400

Yes

Yes

−0.2559 (0.2028)

4.1384*** (1.1416)

−0.0077 (0.1171)

0.0732 (0.1050)

0.81

0.90

1239

Yes

Yes

0.68

0.83

1313

Yes

Yes

−0.0277 (0.0427)

−0.1063 (0.4588)
0.0404 (0.0344)

−0.0373 (0.0255)
−0.6734*** (0.0870)

0.0191 (0.0136)

−0.0077 (0.0114)

−0.0510 (1.0624)

−0.0395* (0.0164)

0.0021† (0.0012)

−0.0004 (0.0011)

1.7718*** (0.2194)
−0.0375 (0.6113)

and

R square

1400

Yes

Year dummies

1.0419*** (0.0867)

6.9868 (2.4533)

−0.0615 (0.0465)

0.0257 (0.0580)

−10.4276** (3.5898)

0.0929 (0.0673)

0.0016 (0.0258)

9.4684 (14.5324)

0.1871*** (0.0431)

−0.5727*** (0.0922)

3.4782*** (0.8112)

Model 6
Tobin’s Q

Production

N

Yes

Firm dummies

R&D intensity × Award dummy

0.0631** (0.0223)

2.0554*** (0.2860)

2.7786*** (0.6626)
−6.9192** (2.4306)

−0.2053 (1.4341)

−0.0075* (0.0034)

−0.0143 (0.0125)

1.5235*** (0.1060)

Model 5
Cost/sales

in

Interaction effects

0.0306* (0.0129)

Award dummy

−0.0219 (0.0143)

0.0104 (0.0113)

−1.3209 (0.9933)

−1.7305** (0.5921)

−0.0877 (0.2083)

10.4069 (30.4220)

0.2476* (0.1252)

4.3388*** (0.2231)

−16.9791*** (2.4839)

Model 4
Sales
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R&D intensity

0.5205*** (0.0502)

0.6941 (0.7464)

−0.0254 (0.1894)

P&E newness

Direct effects

1.0765*** (0.2732)

−0.0986 (0.0668)

Debt/total assets

−30.9236*** (3.4541)

0.4882*** (0.0472)

−0.0032 (0.1000)
−23.3463 (17.0412)

0.0437† (0.0249)
−0.4195 (1.9354)

Alliance

Diversification

1.0419*** (0.0887)

2.5452* (1.1931)
−0.8269*** (0.1724)

1.8819*** (0.2584)
−0.3352*** (0.0399)

−2.9249*** (0.6592)

Model 3
Oper income

Firm size

Model 2
ROS

Intercept

Controls

Model 1
ROA

Table 10. Results of Panel Regression Analyses with 3-Year Lag for R&D Intensity
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7. Discussion and Conclusion
By analyzing a sample of more than one thousand publicly traded firms that won innovation awards during
1998–2003, this study empirically tests the influence of
an effective innovation program on firm performance.
We find that over an 8-year period from 4 years before to 3 years after the year of winning the first innovation award, the test sample’s mean (median) change
in operating income exceeds that of a control sample
by 39.1% (36.2%). Over the same time span, the control-adjusted mean (median) changes in ROA and ROS
are 32.6% (23.5%) and 34.5% (24.1%), respectively. Together, these findings provide strong support to the
view that an effective innovation program improves
organizational profitability.
Our evidence also suggests that effective innovation
programs significantly increase revenue and cost efficiency. From years −4 to +3, the test sample outperforms the control in terms of mean (median) change in
sales by 39.3% (20.7%), and the mean (median) change
in cost per dollar of sales is −5.5% (−3.8%) when compared with the control group. Furthermore, the test
sample has better market valuation; over the period, the
control-adjusted mean (median) change in Tobin’s Q is
23.7% (3.16%).
The results from the panel regression analysis are
largely consistent. Over our study period, the test
firms persistently outperform the sample firms in
terms of all six performance criteria. In addition, the
results show that besides its direct influence, implementing an effective innovation program can also indirectly contribute to an increase in profitability by
improving R&D efficiencies.
This study contributes to knowledge about the value
of effective innovation programs. Of interest to note,
our event-study results are based on samples matched
for R&D intensity. Thus, the observed difference in performance is not an outcome of the disparity of R&D
expenditure, but rather how effectively firms implement their innovation strategies. In this way, our findings advance understanding of the importance of innovation effectiveness, a key aspect of the innovation
process that has been largely ignored by previous research. Our results also shed light on the on-going debate about whether R&D adequately reflects a firm’s
innovation activity. Proponents have argued that the
amount of resources a firm commits to R&D signals its
innovation effort and strategic orientation. They claim
that R&D is a reasonable indicator of innovation considering the fact that firms’ true innovation capabilities are
often hard to observe directly. Other researchers, however, stress that R&D is only an input to the innovation process (e.g., Heeley et al. 2007, Kochhar and Da-
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vid 1996), and the utility of this measure is constrained
given the pattern of diminishing return of R&D spending (Graves and Langowitz 1993). That is, the more a
firm devotes to R&D, the lower its innovation productivity. Our study adds to this debate by showing direct
evidence that firms with similar levels of R&D spending may have substantially different quality of innovation outputs. Thus, innovation management scholars
should be cautious about the limitations of R&D-based
measures. They might consider applying multiple innovation measures at the same time to capture the richness
and various dimensions of the concept.
The findings reported in the study also offer insights
to the dynamics of competence construction within organizations. Danneels points out that while “studies
consistently showed a positive impact of project-firm
synergy (the extent to which the project can draw on
existing in-house resources and skills) on new product performance … studies have not considered the
reverse direction of the product innovation-competence relation, that is, the effect that new product projects in turn have on the firm’s competences and its trajectory of renewal” (2002, p. 1096). Through a field
study of five firms in high-tech sectors, the author detects that the reverse relation does seem to exist (at
least is salient in the selected firms for that research).
This finding is consistent with the emerging literature
on dynamic capabilities, which posits that innovation
constitutes a meta-capability that assists to “integrate,
build, and reconfigure” competences for competitive advantages (Teece 2007, Teece et al. 1997, Winter
2003). Whereas the extant dynamic capabilities literature on this focus is mostly concerned with how R&D
affects future product development (e.g., Rothaermel
and Hess 2007), we concentrate on the impact of innovation on more general firm operations. We find that
an effective innovation program is beneficial to firms
in terms of nurturing their abilities to generate revenue
and sales, to control and reduce operating costs, and to
attract additional investment by influencing investors’
perception of the firms’ future growth opportunities.
In doing so, we respond to Danneels’s (2002) call for
more research on the role of innovation in firm competence development.
Our finding that the award-winning firms experience significant performance improvement both before
and after receiving the award are congruent with that of
Roberts (1999), which demonstrates that innovation propensity leads to persistent profitability. Whereas Roberts’s study focuses on product innovation in pharmaceutical firms, we are able to show that the association
between innovation and sustained performance is more
generic in the sense that it is applicable to assorted innovations and holds in a wide range of industry con-
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texts. One possible explanation of the sustained competitive advantages is that engaging in effective innovation
programs permits firms to develop skills in rejuvenating themselves. This ability, once learned, in turn offers guidelines for firms to stay at a high level of innovativeness. In this regard, a firm’s innovation ability
is cumulative and path-dependent (Roberts and Amit
2003). This accounts for why companies, such as Apple,
Google, IBM, and Procter & Gamble have been continuously ranked as the world’s “most innovative companies” by Businessweek and other business press. A recent
analysis of innovation leaders has revealed that these
companies are successful in delivering “significant and
sustained growth based on clear strategic ambitions,
fast exploitation of new insights and effective collaboration across the innovation arena” (Innovaro 2008). These
firms know not only how to innovate but also how to
make their innovation processes effective.
There are several limitations with this work. First, not
all innovation awards were created equal, with some
awards issued by independent agencies while others are
offered by a firm to its supplier. This difference could be
relevant because the awards vary in their evaluation criteria or standards, and thus could have implied different
levels of innovation. Nevertheless, the results show that
award winners reap significant financial rewards over
control firms, regardless of the award type. Second, we
used company-wide financial data, whereas an award
might be given to a product or service that is offered by
an unit of a large firm, which may result in an underestimate of the benefits from award-winning events. However, this is a common practice in similar research due
to the difficulty in obtaining unit-specific financial performance data (see Hendricks and Singhal 1996, 1997b).
Third, a firm is likely to win multiple awards from multiple sources. The number of awards as well as the nature of the award may indicate different levels of performance impact. However, only the first award was
considered in this study, regardless of the award type.
This may not be a major limitation as it only makes our
tests more conservative.
There are several research opportunities for future
studies. First, our results provoke an important question: What accounts for an effective innovation program? In other words, why do firms differ in their innovation effectiveness? It is possible that the effectiveness
of an innovation program depends on the support of
other organizational systems. For example, Damanpour
and Evan’s (1984) study indicates that a balance between technical and social systems is required for optimal innovation outputs. Gibson and Gibbs (2006) show
that the presence of a well designed virtual network system can facilitate team cooperation. As such, future research should examine how these systems may affect (or
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possibly jointly influence) firms’ propensity to receive
innovation awards. Second, the main focus of the study
has been on operational and financial performance. Yet
an equally important issue is how an effective innovation program can enhance firms’ subsequent innovation
performance. In analyses not reported in this study, we
regressed patent counts and patent citations on the variables listed in Tables 9 and 10.9 We find that award winning has significant impact (p < 0.01) on the dependent
variables in both 1-year lag and 3-year lag models. This
suggests that award winning is self-reinforcing. These
results are preliminary and require replication over a
longer time period. Thus, future research in this direction is warranted. Third, given our finding of the longlasting competitive advantages of effective innovation
programs, specifying the underlying mechanisms of
such benefits might be a fruitful avenue for future research. Survey research can be conducted to provide
an in-depth examination on how awardees successfully
carry out their innovations. Survey data may also be collected from both award winners and control firms to
compare their differences in organizational factors and
implementation process. In addition, as the winning of
innovation awards is not a direct measure of innovation effectiveness, future survey-based research can help
generate additional evidence of the validity of using
award winning as a proxy for the effectiveness of an innovation program. Finally, to better understand the role
of award characteristics, future research might investigate how the type of award, the time of the award, and
the number of awards are related to firm performance.
Notes
1. Blau and McKinley (1979) also used award winning as an
indicator of successful innovation in a study of architectural
firms on the impact of organizational structures and environmental characteristics on firm innovativeness. We thank
an anonymous reviewer for this reference.
2. We checked a number of other innovation awards (e.g., DuPont Awards for Innovation in Packaging, Innovation Excellence Award, Best of What’s New, etc.) and found similar
requirement for application.
3. Capon et al. (1990) provided a summary of early studies on
the relevant topic.
4. An extraordinary item is a gain or loss in a firm’s earnings
due to a non-recurring event that is out of the firm’s control.
5. We distinguish between high-impact-vs.-minor innovations and radical-vs.-incremental innovations. Whereas the
former classification concerns what degree of social impact
an innovation has, the latter focuses on the way the innovation is related to previous ones (see Banbury and Mitchell 1995, Jansen et al. 2006). A high-impact innovation can be
incremental. For example, Microsoft received the Technical
Innovation Award for its Office 2000 VBA in 2000 and the
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Software Product of the Year Award for its Office v. X exclusively used in Mac operating system in 2001. These products
are improved or updated versions of previous offerings.
6. By matching ROA, we provide additional control for the
possibility that financially successful firms are more likely to
win innovation awards, although financial performance is
commonly not a criterion for selection of innovation award
winners.
7. We thank an anonymous reviewer for pointing out this
issue.
8. We also constructed a 3-year window alliance variable to
take account for the possible variation in alliance duration.
The results are qualitatively the same.
9. The results are available from authors.
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